These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 24530618)

  • 1. Injectable, self-gelling, biodegradable, and immunomodulatory DNA hydrogel for antigen delivery.
    Nishikawa M; Ogawa K; Umeki Y; Mohri K; Kawasaki Y; Watanabe H; Takahashi N; Kusuki E; Takahashi R; Takahashi Y; Takakura Y
    J Control Release; 2014 Apr; 180():25-32. PubMed ID: 24530618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved sustained release of antigen from immunostimulatory DNA hydrogel by electrostatic interaction with chitosan.
    Ishii-Mizuno Y; Umeki Y; Onuki Y; Watanabe H; Takahashi Y; Takakura Y; Nishikawa M
    Int J Pharm; 2017 Jan; 516(1-2):392-400. PubMed ID: 27884715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nasal delivery of Japanese cedar pollen Cryj1 by using self-gelling immunostimulatory DNA for effective induction of immune responses in mice.
    Ishii-Mizuno Y; Umeki Y; Takahashi Y; Kato Y; Takabayashi T; Fujieda S; Takakura Y; Nishikawa M
    J Control Release; 2015 Feb; 200():52-9. PubMed ID: 25553824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-assembling CpG DNA nanoparticles for efficient antigen delivery and immunostimulation.
    Rattanakiat S; Nishikawa M; Takakura Y
    Eur J Pharm Sci; 2012 Sep; 47(2):352-8. PubMed ID: 22771546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retardation of Antigen Release from DNA Hydrogel Using Cholesterol-Modified DNA for Increased Antigen-Specific Immune Response.
    Umeki Y; Saito M; Takahashi Y; Takakura Y; Nishikawa M
    Adv Healthc Mater; 2017 Oct; 6(20):. PubMed ID: 28726304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and development of nanosized DNA assemblies in polypod-like structures as efficient vehicles for immunostimulatory CpG motifs to immune cells.
    Mohri K; Nishikawa M; Takahashi N; Shiomi T; Matsuoka N; Ogawa K; Endo M; Hidaka K; Sugiyama H; Takahashi Y; Takakura Y
    ACS Nano; 2012 Jul; 6(7):5931-40. PubMed ID: 22721419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined encapsulation of a tumor antigen and immune cells using a self-assembling immunostimulatory DNA hydrogel to enhance antigen-specific tumor immunity.
    Umeki Y; Saito M; Kusamori K; Tsujimura M; Nishimura M; Takahashi Y; Takakura Y; Nishikawa M
    J Control Release; 2018 Oct; 288():189-198. PubMed ID: 30219278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vitro and In Vivo Stimulation of Toll-Like Receptor 9 by CpG Oligodeoxynucleotides Incorporated Into Polypod-Like DNA Nanostructures.
    Takahashi Y; Maezawa T; Araie Y; Takahashi Y; Takakura Y; Nishikawa M
    J Pharm Sci; 2017 Sep; 106(9):2457-2462. PubMed ID: 28385547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An injectable, low-toxicity phospholipid-based phase separation gel that induces strong and persistent immune responses in mice.
    Han L; Xue J; Wang L; Peng K; Zhang Z; Gong T; Sun X
    Biomaterials; 2016 Oct; 105():185-194. PubMed ID: 27522253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced Immunostimulatory Activity of CpG Oligodeoxynucleotide by the Combination of Mannose Modification and Incorporation into Nanostructured DNA.
    Liao W; Akahira S; Hara RI; Wada T; Kusamori K; Takakura Y; Nishikawa M
    Biol Pharm Bull; 2020; 43(8):1188-1195. PubMed ID: 32741939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. pH-sensitive polymer-modified liposome-based immunity-inducing system: Effects of inclusion of cationic lipid and CpG-DNA.
    Yoshizaki Y; Yuba E; Sakaguchi N; Koiwai K; Harada A; Kono K
    Biomaterials; 2017 Oct; 141():272-283. PubMed ID: 28704679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient delivery of immunostimulatory DNA to mouse and human immune cells through the construction of polypod-like structured DNA.
    Uno S; Nishikawa M; Mohri K; Umeki Y; Matsuzaki N; Takahashi Y; Fujita H; Kadowaki N; Takakura Y
    Nanomedicine; 2014 May; 10(4):765-74. PubMed ID: 24333587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Separable nanocomposite hydrogel microneedles for intradermal and sustained delivery of antigens to enhance adaptive immune responses.
    Zheng Y; Li Z; Li S; Zhao P; Wang X; Lu S; Shi Y; Chang H
    Acta Biomater; 2024 Sep; 185():203-214. PubMed ID: 39053817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CpG-DNA stimulates cellular and humoral immunity and promotes Th1 differentiation in aged BALB/c mice.
    Maletto B; Rópolo A; Morón V; Pistoresi-Palencia MC
    J Leukoc Biol; 2002 Sep; 72(3):447-54. PubMed ID: 12223511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA nanotechnology-based composite-type gold nanoparticle-immunostimulatory DNA hydrogel for tumor photothermal immunotherapy.
    Yata T; Takahashi Y; Tan M; Nakatsuji H; Ohtsuki S; Murakami T; Imahori H; Umeki Y; Shiomi T; Takakura Y; Nishikawa M
    Biomaterials; 2017 Nov; 146():136-145. PubMed ID: 28918263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant activity of CpG-ODN formulated as a liquid crystal.
    Sánchez Vallecillo MF; Ullio Gamboa GV; Palma SD; Harman MF; Chiodetti AL; Morón G; Allemandi DA; Pistoresi-Palencia MC; Maletto BA
    Biomaterials; 2014 Mar; 35(8):2529-42. PubMed ID: 24382332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposome-encapsulated CpG oligodeoxynucleotides as a potent adjuvant for inducing type 1 innate immunity.
    Suzuki Y; Wakita D; Chamoto K; Narita Y; Tsuji T; Takeshima T; Gyobu H; Kawarada Y; Kondo S; Akira S; Katoh H; Ikeda H; Nishimura T
    Cancer Res; 2004 Dec; 64(23):8754-60. PubMed ID: 15574787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel oligodeoxynucleotide agonists of TLR9 containing N3-Me-dC or N1-Me-dG modifications.
    Putta MR; Zhu F; Li Y; Bhagat L; Cong Y; Kandimalla ER; Agrawal S
    Nucleic Acids Res; 2006; 34(11):3231-8. PubMed ID: 16798912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-encapsulation of an antigen and CpG oligonucleotides into PLGA microparticles by TROMS technology.
    San Román B; Irache JM; Gómez S; Tsapis N; Gamazo C; Espuelas MS
    Eur J Pharm Biopharm; 2008 Sep; 70(1):98-108. PubMed ID: 18501572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biodegradable thermosensitive injectable PEG-PCL-PEG hydrogel for bFGF antigen delivery to improve humoral immunity.
    Gong CY; Shi S; Peng XY; Kan B; Yang L; Huang MJ; Luo F; Zhao X; Wei YQ; Qian ZY
    Growth Factors; 2009 Dec; 27(6):377-83. PubMed ID: 19919526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.